Bylo, this has interested me for a while mate, immutep has targeted patents for both keytruda and opdivo......
so far only keytruda has been used in research....whether BMS aren't interested, even been approached I don't know,
but there must be a reason for targeting opdivo in the first place even though it hasn't been followed up on at
this stage that we know of....
Overnight Market report, page-1485
-
- There are more pages in this discussion • 1,347 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $421.2M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.0¢ | $1.540M | 5.332M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 302190 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 50965 | 2 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |